DA
Daniel Abele
COVID-19SARS-CoV-2Agent-based modelingCovid-19epidemiologyInfectious diseasesCommunicable Disease ControlCommunicable DiseasesComputer SimulationCoronavirus disease
On Valency
published · living versionsW_r6hauw2g·v1 · currentpublished
Manual binding and semi-automated interface generation for efficient simulation backends with user-friendly frontends: A~demonstration for epidemic use cases
with Maximilian Betz, Daniel-Michel Richter, René Schmieding, Henrik Zunker +1
1 version
Preprints & journals
5 papers in the corpus · 2020–2026MEmilio: a high performance Modular EpideMIcs simuLatIOn software for multi-scale and comparative simulations of infectious disease dynamics.42660986 · Bicker, Julia, Gerstein, Carlotta, Kerkmann, David et al.2026 · 0 citationsScientific reports. 2026;16(1)
Agent-based modeling for realistic reproduction of human mobility and contact behavior to evaluate test and isolation strategies in epidemic infectious disease spread.40446545 · Kerkmann, David, Korf, Sascha, Nguyen, Khoa et al.2025 · 17 citationsComputers in biology and medicine. 2025;193:110269
Appropriate relaxation of non-pharmaceutical interventions minimizes the risk of a resurgence in SARS-CoV-2 infections in spite of the Delta variant.35576211 · Koslow, Wadim, Kühn, Martin J, Binder, Sebastian et al.2022 · 22 citationsPLoS computational biology. 2022;18(5):e1010054
Regional opening strategies with commuter testing and containment of new SARS-CoV-2 variants in Germany.35379190 · Kühn, Martin J, Abele, Daniel, Binder, Sebastian et al.2022 · 21 citationsBMC infectious diseases. 2022;22(1):333
Assessment of effective mitigation and prediction of the spread of SARS-CoV-2 in Germany using demographic information and spatial resolution.34216635 · Kühn, Martin J, Abele, Daniel, Mitra, Tanmay et al.2021 · 40 citationsMathematical biosciences. 2021;339:108648
Career total: 39 works. 5 are in this corpus.
Profile built from the corpus for this byline.
Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.